Cargando…

Correction to: Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia

Detalles Bibliográficos
Autores principales:	Tiede, Andreas, Worster, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208678/ https://www.ncbi.nlm.nih.gov/pubmed/30267155 http://dx.doi.org/10.1007/s00277-018-3504-5

Ejemplares similares

Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia
por: Tiede, Andreas, et al.
Publicado: (2018)

The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors
por: Meeks, Shannon L., et al.
Publicado: (2019)

Correction: Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings
por: Grounds, R Michael, et al.
Publicado: (2005)

Preclinical trauma studies of recombinant factor VIIa
por: Schreiber, Martin A, et al.
Publicado: (2005)

Correction to: Efmoroctocog Alfa: A Review in Haemophilia A
por: Frampton, James E.
Publicado: (2021)

Correction to: Eftrenonacog Alfa: A Review in Haemophilia B
por: Lamb, Yvette N., et al.
Publicado: (2023)

Use of recombinant factor VIIa in orthotopic liver transplant
por: Bhatia, Pradeep
Publicado: (2011)

Correction to: Nonacog Beta Pegol: A Review in Haemophilia B
por: Syed, Yahiya Y.
Publicado: (2018)

Correction to: Damoctocog Alfa Pegol: A Review in Haemophilia A
por: Paik, Julia, et al.
Publicado: (2019)

Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
por: Zollner, S, et al.
Publicado: (2014)

Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage
por: Kissela, Brett M, et al.
Publicado: (2008)

Recombinant factor VIIa in severe trauma: further study needed
por: Galvan, Dan A, et al.
Publicado: (2006)

Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants
por: Dang, Chi N, et al.
Publicado: (2010)

Recombinant Factor VIIa: Hemostatic Adjunct in the Coagulopathic Burn Patient
por: Martin, Jeremiah T., et al.
Publicado: (2009)

The utility of recombinant factor VIIa as a last resort in trauma
por: Mamtani, Rishi, et al.
Publicado: (2012)

Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
por: Yampolsky, Natalie, et al.
Publicado: (2014)

Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review
por: Repessé, Xavier, et al.
Publicado: (2013)

A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project
por: Lentz, Steven R, et al.
Publicado: (2014)

The use of recombinant factor VIIa as a haemostatic agent in ICU patients
por: Vernikos, P, et al.
Publicado: (2004)

Predicting response to recombinant activated factor VIIa administration in the critically ill
por: Pugh, R, et al.
Publicado: (2008)

Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients
por: Park, Jeong A
Publicado: (2016)

Recombinant factor VIIa and factor VIII treatment for acquired factor VIII deficiency: a case of repeated thrombotic endotracheal occlusion in a mechanically ventilated patient
por: Lauer, Stefan, et al.
Publicado: (2011)

Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven(®))
por: Viuff, D., et al.
Publicado: (2008)

Evaluation of Recombinant Factor VIIa Treatment for Massive Hemorrhage in Patients with Multiple Traumas
por: Koh, Young Rae, et al.
Publicado: (2012)

Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma
por: Mohr, Alicia M, et al.
Publicado: (2005)

Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
por: Puetz, John
Publicado: (2010)

Thromboembolic risks of recombinant factor VIIa use in warfarin-associated intracranial hemorrhage
por: Chou, S, et al.
Publicado: (2011)

Use of Recombinant Factor VIIa in Symptomatic Intracerebral Hemorrhage Following Intravenous Thrombolysis
por: Yaghi, Shadi, et al.
Publicado: (2015)

Emicizumab in acquired haemophilia A: about two clinical cases and literature review
por: Hansenne, Amandine, et al.
Publicado: (2021)

Recombinant Factor VIIa in Post-partum Hemorrhage: A New Weapon in Obstetrician's Armamentarium
por: Magon, Navneet, et al.
Publicado: (2012)

Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings
por: Grounds, R Michael, et al.
Publicado: (2005)

The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
por: Lin, Y, et al.
Publicado: (2012)

Recombinant factor VIIa for variceal bleeding in liver cirrhosis: still only a hope
por: Qi, Xingshun, et al.
Publicado: (2017)

Emergency cesarean section in glanzmann thrombasthenia: Anaesthetic management without recombinant factor VIIa
por: Priyanka, Andal, et al.
Publicado: (2023)

Burden of mild haemophilia A: Systematic literature review
por: Peyvandi, Flora, et al.
Publicado: (2019)

Violin concertos in C major, Hob. VIIa:1 ; in G major, Hob. VIIa:4 ; in A major, Hob. VIIa:3 /
por: Haydn, Joseph, 1732-1809
Publicado: (1989)

Acquired Haemophilia A: An Intriguing Disease
por: Mazzucconi, Maria Gabriella, et al.
Publicado: (2020)

Acquired Haemophilia Associated with Urticarial Vasculitis
por: Attout, Hassene
Publicado: (2020)

Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
por: Chapman, Scott A, et al.
Publicado: (2014)

Recombinant factor VIII Fc for the treatment of haemophilia A
por: Hermans, Cedric, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ravjk1vicr8rpoplrg63b4d4n6